|Bid||0.00 x 900|
|Ask||0.00 x 1400|
|Day's range||50.60 - 52.42|
|52-week range||45.44 - 64.02|
|Beta (5Y monthly)||1.18|
|PE ratio (TTM)||129.48|
|Forward dividend & yield||1.80 (3.48%)|
|Ex-dividend date||30 June 2022|
|1y target est||N/A|
Ventas (VTR) is well-positioned to gain from its diverse healthcare real estate portfolio and a healthy balance-sheet position. Yet, tenant concentration risk and interest rate hikes are major woes.
S&P Global Ratings upgrades Ventas' (VTR) outlook to stable from negative, highlighting improving fundamentals driven by senior housing recovery. Moreover, it maintains the rating at BBB+.
In order to justify the effort of selecting individual stocks, it's worth striving to beat the returns from a market...